CPD Login
Covid-19: The great mental health equaliser
There is no country, society, or culture where people with mental illness have the same societal value as people without…
Covid-19 creates a new norm of unpredictability
The new normal is defined as ‘a current situation, social custom etc, that is different from what has been experienced…
When mothers get PMAD
Worldwide, as many as one in five women experience some type of perinatal mood and anxiety disorder (PMAD). AUTHOR: Rene…
Romance and schizophrenia: An odd couple
Dating in an era of social media can be daunting. Dating for people living with schizophrenia is doubly daunting. This…
ADHD in the time of Covid-19
In a webinar that took place last year, Dr Jannie van der Westhuizen presented on the importance of addressing ADHD…
Talk therapy and medication – a powerful combination
One in every 100 South Africans is impacted by schizophrenia. Healthcare professionals may recommend daily, oral medication or long-term injectables.
Depression: ‘Main gateway’ to suicidal behaviour
Major depressive disorder (MDD) is a debilitating mood disorder associated with excess mortality. Despite the availability of effective treatment, it…
3 new ADHD guidelines published
The first guidelines on the management of children with complex attention deficit hyperactivity disorder (ADHD) werepublished recently by the American…
Risky behaviour may signal depression
Men in South Africa are four times more likely to commit suicide than women. This is one of the findings…
Summertime sadness
More than 800 000 people commit suicide every year, accounting for 1.5% of the total deaths in the world. According to…
Living with schizophrenia during a pandemic
Physiotherapists can help Covid-19 patients with their transition back to wellness and function.
Anosognosia a major challenge in schizophrenia
Anosognosia or poor insight is a cardinal symptom of schizophrenia. Between 57% to 98% of patients are affected. In essence…
Adult ADHD and depression
Is adult ADHD a thing, and if so how does one treat it, as well as its frequent comorbidity with…
The case for trazodone in MDD
Fewer than 25% of individuals with major depressive disorder receive adequate treatment.
The ADHD continuum
Attention-deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders, affecting children, adolescents and adults. If left untreated,…
Depression in perimenopause not assessed by doctors
New study documents lack of screening for depression and need to better educate healthcare providers on women’s mental health issues…
Depression: The South African context
The disease profile of depression in sub-Saharan and South Arica differs in significant ways from that encountered in the rest…
Why do patients with schizophrenia die young?
Patients with schizophrenia have a higher risk of mortality compared to matched controls, said Prof Bonga Chiliza, president of the…
Tailoring methylphenidate to patient needs
Psychostimulant medications such as methylphenidate remain the most effective pharmacological treatment for ADHD, but physicians need to be cognisant of…
How effective are LAIs in managing schizophrenia?
Schizophrenia, a remitting and relapsing neurodevelopmental disorder, has a lifetime risk of about 1%. The World Health Organization ranks it…
